Crinetics Pharmaceuticals EPS Basic from Accounting Change (Quarterly) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

43.44 -0.56 (-1.27%) USD | NASDAQ | Feb 20, 16:00

43.44 0.00 (0.00%) After-Hours: 16:42

View EPS Basic from Accounting Change (Quarterly) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
GT Biopharma, Inc.	--
Axsome Therapeutics, Inc.	--
Sutro Biopharma, Inc.	--
Gossamer Bio, Inc.	--